Document Classification

Section Type: RESULTS

Text: Within the CKD group, treatment with carvedilol decreased the risks of all-cause mortality (hazard ratio [HR], 0. 76 ; 95 % confidence interval [CI], 0. 63 to 0. 93 ; P = 0. 007), cardiovascular mortality (HR, 0. 76 ; 95 % CI, 0. 62 to 0. 94 ; P = 0. 011), HF mortality (HR, 0. 68 ; 95 % CI, 0. 52 to 0. 88 ; P = 0. 003), first hospitalization for HF (HR, 0. 74 ; 95 % CI, 0. 61 to 0. 88 ; P = 0. 0009), and the composite of cardiovascular mortality or HF hospitalization (HR, 0. 75 ; 95 % CI, 0. 65 to 0. 87 ; P < 0. 001) but was without significant effect on sudden cardiac death (HR, 0. 76 ; 95 % CI, 0. 56 to 1. 05 ; P = 0. 098).